Literature DB >> 20130354

Neurological sequelae of hypoxic-ischemic brain injury.

Christine Lu-Emerson1, Sandeep Khot.   

Abstract

Hypoxic-ischemic brain injury (HI-BI) after cardiac arrest commonly results in neurological injury and long term dysfunction, with outcomes ranging from coma and vegetative states to functional disability with various degrees of dependence. Increased rates of bystander CPR and cardiac defibrillation has led to a rapid increase in successful resuscitations. Patients who reach the hospital after cardiac arrest may develop various neurological deficits or clinical syndromes that may preclude recovery to their premorbid baseline. Consequently, clinicians are faced with not only predicting outcome regarding wakefulness and independence but also with long term therapeutic management. Several neurological syndromes have been reported as consequences of HI-BI. This review will describe some of the more common syndromes seen after HI-BI, including the various levels of arousal, seizures, myoclonus, movement disorders, cognitive impairments, and other specific neurological abnormalities.

Entities:  

Mesh:

Year:  2010        PMID: 20130354     DOI: 10.3233/NRE-2010-0534

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  18 in total

Review 1.  Acute Symptomatic Seizures and Provoked Seizures: to Treat or Not to Treat?

Authors:  Nisali Gunawardane; Madeline Fields
Journal:  Curr Treat Options Neurol       Date:  2018-08-23       Impact factor: 3.598

2.  Functional integrity in children with anoxic brain injury from drowning.

Authors:  Mariam Ishaque; Janessa H Manning; Mary D Woolsey; Crystal G Franklin; Elizabeth W Tullis; Christian F Beckmann; Peter T Fox
Journal:  Hum Brain Mapp       Date:  2017-07-31       Impact factor: 5.038

3.  Neural Tract Degeneration Correlates with Functional Impairment in Patients with Anoxic Brain Injury: A Tract-based Spatial Statistics Study.

Authors:  Ji-Yun Park; Sung Ho Park; Jeong-Hee Yang; Han Do Lee; Jiho Lee; Ki-Hyun Byeon; Seo Young Park; Dongseok Yang
Journal:  Neurosci Bull       Date:  2020-04-06       Impact factor: 5.203

4.  Zebrafish as an alternative model for hypoxic-ischemic brain damage.

Authors:  Xinge Yu; Yang V Li
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-04-20

5.  Injury of the lower ascending reticular activating system in patients with hypoxic-ischemic brain injury: diffusion tensor imaging study.

Authors:  Sung Ho Jang; Seong Ho Kim; Hyoung Won Lim; Sang Seok Yeo
Journal:  Neuroradiology       Date:  2014-08-15       Impact factor: 2.804

6.  Forebrain ischemia triggers GABAergic system degeneration in substantia nigra at chronic stages in rats.

Authors:  B Lin; S Levy; A P Raval; M A Perez-Pinzon; R A Defazio
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-10-14

7.  Alterations in Purkinje cell GABAA receptor pharmacology following oxygen and glucose deprivation and cerebral ischemia reveal novel contribution of β1 -subunit-containing receptors.

Authors:  Melissa H Kelley; Justin Ortiz; Kaori Shimizu; Himmat Grewal; Nidia Quillinan; Paco S Herson
Journal:  Eur J Neurosci       Date:  2012-11-26       Impact factor: 3.386

Review 8.  Hypoxia after stroke: a review of experimental and clinical evidence.

Authors:  Phillip Ferdinand; Christine Roffe
Journal:  Exp Transl Stroke Med       Date:  2016-12-07

9.  Lenticulostriate arterial distribution pathology may underlie pediatric anoxic brain injury in drowning.

Authors:  Mariam Ishaque; Janessa H Manning; Mary D Woolsey; Crystal G Franklin; Elizabeth W Tullis; Peter T Fox
Journal:  Neuroimage Clin       Date:  2016-01-23       Impact factor: 4.881

10.  Bystin (BYSL) as a possible marker of severe hypoxic-ischemic changes in neuropathological examination of forensic cases.

Authors:  Mieszko Olczak; Dominik Chutorański; Magdalena Kwiatkowska; Dorota Samojłowicz; Sylwia Tarka; Teresa Wierzba-Bobrowicz
Journal:  Forensic Sci Med Pathol       Date:  2018-01-18       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.